SCHEMBL7218324

SCHEMBL7218324

Cc1cc(NC(=O)c2c[nH]c3c2-c2nn(C)cc2CCC3)no1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.42
RAB9A P51151 9/20 0.41
NPC1 O15118 8/20 0.41
SMN1; SMN2 Q16637 7/20 0.41
CYP1A2 P05177 3/20 0.41
CYP2C19 P33261 3/20 0.41
ALDH1A1 P00352 5/20 0.39
PKM P14618 2/20 0.39
HPGD P15428 1/20 0.39
POLB P06746 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
TSHR P16473 2/20 0.38
KDM4E B2RXH2 2/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6834426 0.83 DRD4 (0.37)
SCHEMBL7222852 0.82 NPC1 (0.43) MAPTRAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL6834425 0.81 DRD4 (0.36)
SCHEMBL6834466 0.81 KMT2A (0.37) MAPTRAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL6834487 0.81 GAA (0.43) RAB9ANPC1SMN1; SMN2ALDH1A1PKM
SCHEMBL6834309 0.80 LMNA (0.42) MAPTRAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL7222006 0.78 NPC1 (0.38) RAB9ANPC1ALDH1A1PKMLMNA
SCHEMBL7216813 0.78 F10 (0.39) RAB9ANPC1CYP1A2MEN1KMT2A
SCHEMBL7216812 0.78 NPC1 (0.56) MAPTRAB9ANPC1SMN1; SMN2CYP2C19
SCHEMBL6304803 0.78 DRD4 (0.44) ALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6653471-B2 Tricyclic heteroaromatic compounds containing pyrrole ring; central nervous system disorder treatment; side effect reduction NEUROGEN CORPORATION 2003-11-25 US disclosed